ECMO: Optimization of Its Use
Terminated
- Conditions
- Extracorporeal Membrane Oxygenation Complication
- Registration Number
- NCT02280460
- Lead Sponsor
- Renzo Loyaga Rendon
- Brief Summary
To create a local registry for ECMO patients.
- Detailed Description
To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 921
Inclusion Criteria
- Age >18
- requiring ECMO. For the control,Patients without ECMO admited to ICU.
Exclusion Criteria
- Age<18
- Known prisoner of the state
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All cause mortality 1 year
- Secondary Outcome Measures
Name Time Method all cause mortality 48 hours In-house mortality 30 day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ECMO-related complications in critically ill patients?
How does ECMO compare to conventional mechanical ventilation in managing acute respiratory distress syndrome?
Which biomarkers are associated with improved prognosis in ECMO-treated patients with septic shock?
What adverse events are most common in long-term ECMO therapy and how are they managed?
Are there specific patient subtypes that benefit more from ECMO in cardiac arrest scenarios?
Trial Locations
- Locations (1)
Spectrum Health
🇺🇸Grand Rapids, Michigan, United States
Spectrum Health🇺🇸Grand Rapids, Michigan, United States